Ignite Creation Date:
2024-05-06 @ 7:09 PM
Last Modification Date:
2024-10-26 @ 3:01 PM
Study NCT ID:
NCT05918796
Status:
COMPLETED
Last Update Posted:
2023-08-24
First Post:
2023-06-16
Brief Title:
Comparison Between Bupivacaine and Bupivacaine- Dexamethasone QLB for Postoperative Analgesia
Sponsor:
Ain Shams University
Organization:
Ain Shams University
Study Overview
Official Title:
Ultrasound-guided Quadratus Lumborum Block Using Bupivacaine Versus Bupivacaine - Dexamethasone as Postoperative Analgesia in Laparoscopic Cholecystectomy
Status:
COMPLETED
Status Verified Date:
2023-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The objective of this study is to assess the analgesic sparing effect of adding Dexamethasone to Bupivacaine in Quadratus lumborum block in patients undergoing Laparoscopic cholecystectomy under general anesthesia
Detailed Description:
Background The QLB is an effective analgesic technique for various abdominal wall incisions The QLB covers T7 to L2 dermatomes by the spread of LA drugs either into the paravertebral space or in the thoracolumbar plane through iliohypogastric and ilioinguinal nerves A and C fiber nociceptors mechanoreceptors and high-density network of lumbar sympathetic fibers
Objective To assess the analgesic sparing effect of adding Dexamethasone to Bupivacaine in Quadratus lumborum block in patients undergoing Laparoscopic cholecystectomy under general anesthesia
Patients and Methods Sixty patients scheduled for elective Laparoscopic cholecystectomy surgeries under general anesthesia were included in this study they were divided into two groups Group A perineural dexamethasone and bupivacaine group n30 Those cases will receive 2ml volume of dexamethasone 8mg combined with 18 ml of bupivacaine of 025 concentration Group B perineural bupivacaine group n30 Those cases will receive perineural 18 ml bupivacaine 025 combined with 2 ml normal saline
Objective To assess the analgesic sparing effect of adding Dexamethasone to Bupivacaine in Quadratus lumborum block in patients undergoing Laparoscopic cholecystectomy under general anesthesia
Patients and Methods Sixty patients scheduled for elective Laparoscopic cholecystectomy surgeries under general anesthesia were included in this study they were divided into two groups Group A perineural dexamethasone and bupivacaine group n30 Those cases will receive 2ml volume of dexamethasone 8mg combined with 18 ml of bupivacaine of 025 concentration Group B perineural bupivacaine group n30 Those cases will receive perineural 18 ml bupivacaine 025 combined with 2 ml normal saline
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None